ScienceDex / Researcher record
Lin, Frank
- Division of Basic Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #12,502
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $414,789 | 1 | #19,476 |
| 2018 | $684,370 | 4 | #12,799 |
| 2019 | $760,214 | 5 | #11,758 |
| 2021 | $751,612 | 5 | #13,447 |
| 2022 | $859,316 | 5 | #11,761 |
| 2023 | $842,804 | 5 | #12,502 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20171 record
- FY20184 records
- FY20195 records
- FY20215 records
- FY20225 records
- FY2023 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Lin, Frank as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC012138-01ZIAContact PIPb212 VMT alpha NET in treatment and re-treatment of SSTR+ tumors$337.1Kaward amount
- 1ZIABC011789-07ZIAContact PIPhase 2 study of Lu-177-DOTATATE in inoperable paraganglioma - pheochromocytoa$168.6Kaward amount
- 1ZIABC011895-05ZIAContact PIImproving PSMA-based radioligand therapy via combination radioligand therapy$168.6Kaward amount
- 1ZIABC011826-06ZIAContact PIProtection of Salivary Gland in PSMA-targeted radioligand therapy$84.3Kaward amount
- 1ZIABC011827-06ZIAContact PIPhase 1-2 study of Lu177-DOTATATE and olaparib in neuroendocrine tumors$84.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Lin, Frank as a PI.
FY2023 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardDivision of Basic Sciences - Nci
- 2018$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2021$2M Cumulative Funding